Letters

Developing world needs access to low cost pharmaceutical information from reliable sources

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7219.1265 (Published 06 November 1999) Cite this as: BMJ 1999;319:1265
  1. Neil Pakenham-Walsh, programme manager,
  2. Michael Eddleston, senior house officer,
  3. Manjit Kaur, pharmaceutical adviser
  1. NASP-Health International Network for the Availability of Scientific Publications, Oxford OX1 1HU 101374.3615@compuserve.com
  2. Royal Sussex County Hospital, Brighton BN2 5BE
  3. ECHO International Health Services, Coulsdon, Surrey CR5 2HR

    EDITOR—Hafeez and Mirza have assessed how seriously (or not) pharmaceutical companies take their responsibility to provide information on request to prescribers in Pakistan.1 Two of their conclusions are that “providing information on drugs is not a priority for companies in Pakistan” and that “the decision to respond to a request for more information therefore seems to depend on how …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe